Mediccanna

30/05/2026

A promising new drug, daraxonrasib. showed at a clinical trial at the University of Chicago for the first time to significantly extend the lives of people with pancreatic cancer: https://clinicaltrials.gov/study/NCT06625320

02/05/2026

Cannabis may contain more important components, new research says. 25 new phenolic compounds were found mainly in cannabis leaves, of which 16 were classified as flavoalkaloids (a group that is rarely found in nature). According to Dr. Magriet Muller, an analytical chemist in the LC-MS laboratory of the Central Analytical Facility (CAF) at Stellenbosch University: "Most plants contain highly complex mixtures of phenolic compounds, and while flavonoids occur widely in the plant kingdom, the flavoalkaloids are very rare in nature. The rich and unique non-cannabinoid phenolic profile could be relevant from a biomedical research perspective".

M. Muller, A. de Villiers. Comprehensive two-dimensional liquid chromatographic analysis of Cannabis phenolics and first evidence of flavoalkaloids in Cannabis. Journal of Chromatography A, 2025; 1754: 466023 DOI: 10.1016/j.chroma.2025.466023

27/04/2026

Celebrate King’s Day with us 🇳🇱
Save 10% with code KINGSDAY
Note: We’ll be closed on Monday, April 27.

05/04/2026

Happy Easter :)

05/03/2026

About 27% of Americans take melatonin to fall asleep. However, Dr. Michael Breus, a clinical psychologist and a leading sleep expert worldwide, cautioned against widespread use of melatonin. “Melatonin is a sleep regulator, not a sleep initiator,” he explained, emphasizing that melatonin is a hormone that influences the whole body system.
Unlike melatonin, full-spectrum CBD and RSO actively interact with your endocannabinoid system to dismantle stress, melt away tension, and naturally initiate a deep. Cannabinoids bind to CB1 receptors in the brain and have known sedative properties. It actively decreases sleep latency (the time it takes to fall asleep) and directly induces the physical and mental heaviness associated with tiredness.

02/03/2026

Oregon State University researchers have developed an iron-based nanomaterial that exploits the acidic, high-hydrogen-peroxide environment of tumors to destroy cancer cells from within. By triggering a dual chemical reaction, this therapeutic agent floods cancer cells with oxygen-damaging radicals, inducing lethal stress while leaving healthy tissues unharmed.
(paper: https://www.sciencedaily.com/releases/2026/02/260228093456.htm)

23/02/2026

Exciting new research has identified a specific protein, P2RX7, as a major culprit in helping lung cancer tumors hide from the immune system. By disabling this "shield" on regulatory T cells, scientists were able to boost the body’s natural defenses and significantly slow tumor growth in lab models. Published in Cancer Immunology Research, the findings offer a new approach that could make lung cancer treatments much more effective. https://aacrjournals.org/cancerimmunolres/article-abstract/doi/10.1158/2326-6066.CIR-25-0567/771882/Regulatory-T-cell-sensing-of-extracellular-ATP-via?redirectedFrom=fulltext

16/02/2026

Study Finds Cannabis Usage in Middle Aged and Older Adults Associated With Larger Brain Volume, Better Cognitive Function (source: https://news.cuanschutz.edu/news-stories/study-finds-cannabis-usage-in-middle-aged-and-older-adults-associated-with-larger-brain-volume-better-cognitive-function)

04/02/2026

A recently discovered RNA molecule could enhance survival rates for cancer patients. Researchers at Texas A&M University Health Science Center identified this novel RNA, which is essential for maintaining the integrity of the nucleolus, a vital cellular structure. Their research also indicates that this molecule may affect outcomes in specific blood cancers. (by Wesley P**n, Texas A&M University)

In a recent study, researchers at the Texas A&M University Health Science Center (Texas A&M Health) identify a novel RNA molecule that plays a crucial role in preserving the integrity of a key cellular structure, the nucleolus . Their findings also suggest this molecule may influence patient...

23/01/2026

mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say (BETH MOLE, Arstechnica)

The vaccines are tailor-made to target each patient's unique cancer.